Approved overseas, not yet PBS-listed

Medicines that have an FDA approval on record but do not yet appear anywhere on the Australian Pharmaceutical Benefits Scheme. Being on this list is a factual data comparison, not a judgement — a medicine may be TGA-approved, available privately, or not sought for PBS listing at all.

53 FDA-approved medicines in Voxsanity's dataset have at least one active ingredient that does not appear anywhere on the current PBS Schedule.

Matched by active ingredient, not by product name: the FDA writes “carbidopa and levodopa” where the PBS writes “levodopa + carbidopa”, and salt and dosage-form wording differs on both sides. A further 3 medicines are left off this list because every ingredient is subsidised, just not together as that exact product. Where the two registries use different international names for the same substance, a medicine can still appear here in error, so this count may overstate slightly. It is a data comparison, never a statement that a medicine is unavailable — check with your doctor or pharmacist.

Not medical advice. A medicine's absence from the PBS does not mean it is unavailable in Australia. Verify current availability and subsidised status with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.